EUVIMEDEUVIMED entdecken
Crossref

Bifunctional Behavior of Conformationally Constrained Methamphetamine Analogs: Unexpected Heteroclitic Immune Response and Antagonist Effects Altering Methamphetamine and Fentanyl Pharmacology

Sukhyun Lee, Lisa M Eubanks iD, Bin Zhou, Kim D Janda iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c02002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Sukhyun Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Immunology, The Skaggs Institute for Chemical Biology, Worm Institute of Research and Medicine (WIRM), The Scripps Resear…. Hauptthemen laut MEDLINE: Fentanyl, Methamphetamine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Shadek Family Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methamphetamine addiction is a growing global health crisis with no FDA-approved pharmacotherapies. Vaccination offers a promising therapeutic strategy, yet clinical translation has been limited by immune response inefficacy. Here, we evaluated three methamphetamine vaccine candidates: H1, a conventional hapten based on traditional drug–hapten–vaccine logic, and H2 and H3, two conformationally constrained analogs incorporating pyrrolidine and azetidine scaffolds, respectively. The rigidified hapten H2 produced an unprecedented heteroclitic immune response, with mature antibodies binding methamphetamine with an order of magnitude greater affinity than the immunizing scaffold. Although vaccine haptens are rarely assessed for intrinsic bioactivity, the pyrrolidine scaffold of H2, termed S1, exhibited distinct pharmacology, which was markedly divergent from methamphetamine. S1 is also capable of mitigating not only methamphetamine but also fentanyl-induced physiological effects. Methamphetamine conformational constraint offers a new tool for methamphetamine vaccine development as well as promising therapeutic agents for reversal of methamphetamine behavior and fentanyl-induced toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FentanylMethamphetamineAnimalsHumansMaleMiceHaptensMolecular ConformationStructure-Activity RelationshipBenzene Derivatives

Substanzen

FentanylHaptensMethamphetamine(R)-2-Benzylazetidine HCl SaltBenzene Derivatives

Autor:innen und Institutionen

  • Department of Chemistry and Immunology, The Skaggs Institute for Chemical Biology, Worm Institute of Research and Medicine (WIRM), The Scripps Research Institute, La Jolla, California 92037, United States.

ORCID-Profile: Lisa M Eubanks, Kim D Janda

Förderung

  • Shadek Family Foundation

Zitieren

APA

Lee, S., Eubanks, L. M., Zhou, B., & Janda, K. D. (2025). Bifunctional Behavior of Conformationally Constrained Methamphetamine Analogs: Unexpected Heteroclitic Immune Response and Antagonist Effects Altering Methamphetamine and Fentanyl Pharmacology. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02002

Vancouver

Lee S, Eubanks LM, Zhou B, Janda KD. Bifunctional Behavior of Conformationally Constrained Methamphetamine Analogs: Unexpected Heteroclitic Immune Response and Antagonist Effects Altering Methamphetamine and Fentanyl Pharmacology. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c02002

BibTeX
@article{Lee2025,
  author = {Lee, Sukhyun and Eubanks, Lisa M and Zhou, Bin and Janda, Kim D},
  title = {Bifunctional Behavior of Conformationally Constrained Methamphetamine Analogs: Unexpected Heteroclitic Immune Response and Antagonist Effects Altering Methamphetamine and Fentanyl Pharmacology},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c02002}
}
Kostenlos starten →